ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 181 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,523,534 | -25.8% | 194,567 | -0.1% | 0.01% | -33.3% |
| Q1 2024 | $3,399,986 | -35.6% | 194,730 | -65.3% | 0.02% | -44.4% |
| Q4 2023 | $5,279,208 | +36.7% | 561,021 | +62.3% | 0.03% | +17.4% |
| Q3 2023 | $3,860,922 | -48.1% | 345,651 | -0.5% | 0.02% | -46.5% |
| Q2 2023 | $7,433,247 | -46.9% | 347,348 | +0.3% | 0.04% | -50.0% |
| Q1 2023 | $14,010,640 | -13.7% | 346,455 | -0.7% | 0.09% | -21.8% |
| Q4 2022 | $16,238,179 | -11.1% | 349,058 | -0.9% | 0.11% | -23.6% |
| Q3 2022 | $18,274,000 | +29.9% | 352,303 | +18.4% | 0.14% | +32.1% |
| Q2 2022 | $14,064,000 | -29.0% | 297,532 | +6.9% | 0.11% | -18.0% |
| Q1 2022 | $19,818,000 | -1.9% | 278,423 | +3.1% | 0.13% | -1.5% |
| Q4 2021 | $20,200,000 | +40.1% | 270,130 | +6.4% | 0.14% | +39.2% |
| Q3 2021 | $14,419,000 | +26.2% | 253,814 | -2.2% | 0.10% | +26.0% |
| Q2 2021 | $11,423,000 | -4.4% | 259,553 | +7.1% | 0.08% | -16.3% |
| Q1 2021 | $11,948,000 | +14.3% | 242,257 | -2.4% | 0.09% | 0.0% |
| Q4 2020 | $10,454,000 | -10.8% | 248,320 | -3.0% | 0.09% | -24.6% |
| Q3 2020 | $11,723,000 | -11.7% | 256,064 | -3.1% | 0.12% | -15.3% |
| Q2 2020 | $13,269,000 | +51.1% | 264,261 | +54.7% | 0.14% | +27.4% |
| Q1 2020 | $8,783,000 | +65.7% | 170,785 | +99.1% | 0.11% | +117.3% |
| Q4 2019 | $5,300,000 | +23.6% | 85,787 | +20.2% | 0.05% | -1.9% |
| Q3 2019 | $4,288,000 | -12.4% | 71,374 | +23.1% | 0.05% | -22.1% |
| Q2 2019 | $4,894,000 | +113.5% | 58,004 | +116.3% | 0.07% | +106.1% |
| Q3 2018 | $2,292,000 | +56.0% | 26,822 | +111.6% | 0.03% | +43.5% |
| Q2 2018 | $1,469,000 | -36.8% | 12,677 | -55.9% | 0.02% | -41.0% |
| Q1 2018 | $2,324,000 | +34.7% | 28,720 | -2.3% | 0.04% | +30.0% |
| Q4 2017 | $1,725,000 | +319.7% | 29,400 | +110.1% | 0.03% | +233.3% |
| Q1 2016 | $411,000 | – | 13,992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |